Alibaba Health Information Technology (241N) Stock Price & Analysis
241N Stock Chart & Stats
- Day’s Range
- MXN 58.93 - MXN 58.93
- 52-Week Range
- MXN 58.93 - MXN 58.93
- Previous Close
- MXN 58.93
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- MXN 109.42B
- Enterprise Value
- MXN 63.63B
- Total Cash (Recent Filing)
- MXN 10.45B
- Total Debt (Recent Filing)
- MXN 59.56M
- Price to Earnings (P/E)
- 20.1
- Beta
- 0.00
- Next Earnings
- Dec 02, 2026 (Est.)
- EPS Estimate
- 0.2
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Extremely low leverage gives Alibaba Health substantial financial resilience and reduces interest and refinancing pressure. Growing equity alongside earnings provides a stronger capital base, preserving flexibility to invest in healthcare platforms, products, and services through changing conditions.
Revenue And Margin Recovery
The multi-year revenue expansion and recovery from losses demonstrate that the platform has built greater commercial scale over time. Improved gross and net margins indicate better profitability than the 2022–2023 trough, supporting a more durable earnings base if operational progress continues.
Integrated Healthcare Platform
An integrated online and offline model gives Alibaba Health multiple ways to participate in healthcare product sales, distribution, and digital services. Connections across consumers, pharmacies, brands, and providers can support recurring platform activity and broaden the company’s role in healthcare access.
Bears Say
Decelerating Revenue Growth
Recent top-line growth has slowed sharply after the company’s earlier expansion, which may limit operating leverage and reduce the pace at which earnings can compound. Continued deceleration would make it harder to absorb fixed platform costs and sustain improving profitability.
Weak Cash Conversion
Reported profitability is not converting into cash as strongly as it could, with operating cash flow well below net income in 2026. The free cash flow decline further signals volatility in cash generation, potentially constraining internally funded investment despite the low-debt balance sheet.
Moderate Operating Profitability
Alibaba Health is profitable, but its moderate EBIT margin indicates that operating expenses absorb a substantial portion of gross profit. This leaves less protection against slower growth and means further scale or efficiency improvements may be needed to make earnings more resilient.
Alibaba Health Information Technology News
241N FAQ
What was Alibaba Health Information Technology’s price range in the past 12 months?
What is Alibaba Health Information Technology’s market cap?
When is Alibaba Health Information Technology’s upcoming earnings report date?
How were Alibaba Health Information Technology’s earnings last quarter?
Is Alibaba Health Information Technology overvalued?
Does Alibaba Health Information Technology pay dividends?
What is Alibaba Health Information Technology’s EPS estimate?
How many shares outstanding does Alibaba Health Information Technology have?
What happened to Alibaba Health Information Technology’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Alibaba Health Information Technology?
What is the TipRanks Smart Score and how is it calculated?
Alibaba Health Information Technology Stock Smart Score
Company Description
Alibaba Health Information Technology
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Yong Yu
- Employees
- 1,394
- Website
- www.alihealth.cn
- Address
- HK
Alibaba Health Information Technology (241N) Earnings & Revenues
241N Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 1 | 4 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 8 | 0 | 4 |
